Literature DB >> 25706217

Classification, assessment, prevalence, and effect of personality disorder.

Peter Tyrer1, Geoffrey M Reed2, Mike J Crawford3.   

Abstract

Personality disorders are common and ubiquitous in all medical settings, so every medical practitioner will encounter them frequently. People with personality disorder have problems in interpersonal relationships but often attribute them wrongly to others. No clear threshold exists between types and degrees of personality dysfunction and its pathology is best classified by a single dimension, ranging from normal personality at one extreme through to severe personality disorder at the other. The description of personality disorders has been complicated over the years by undue adherence to overlapping and unvalidated categories that represent specific characteristics rather than the core components of personality disorder. Many people with personality disorder remain undetected in clinical practice and might be given treatments that are ineffective or harmful as a result. Comorbidity with other mental disorders is common, and the presence of personality disorder often has a negative effect on course and treatment outcome. Personality disorder is also associated with premature mortality and suicide, and needs to be identified more often in clinical practice than it is at present.
Copyright © 2015 World Health Organization. Published by Elsevier Ltd/Inc/BV. All rights reserved. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25706217     DOI: 10.1016/S0140-6736(14)61995-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  98 in total

1.  The ICD-11 beta draft is available online.

Authors:  Mario Luciano
Journal:  World Psychiatry       Date:  2015-10       Impact factor: 49.548

2.  Evaluating the assessment of the ICD-11 personality disorder diagnostic system.

Authors:  Joshua R Oltmanns; Thomas A Widiger
Journal:  Psychol Assess       Date:  2019-01-10

Review 3.  A Brief but Comprehensive Review of Research on the Alternative DSM-5 Model for Personality Disorders.

Authors:  Johannes Zimmermann; André Kerber; Katharina Rek; Christopher J Hopwood; Robert F Krueger
Journal:  Curr Psychiatry Rep       Date:  2019-08-13       Impact factor: 5.285

Review 4.  Mentalization-Based Treatment for Personality Disorders: Efficacy, Effectiveness, and New Developments.

Authors:  Jana Volkert; Sophie Hauschild; Svenja Taubner
Journal:  Curr Psychiatry Rep       Date:  2019-03-09       Impact factor: 5.285

5.  Antipathy towards people with personality disorders.

Authors:  Peter Tyrer
Journal:  BJPsych Bull       Date:  2017-04

Review 6.  Impulsivity and Cluster B Personality Disorders.

Authors:  Daniel Turner; Alexandra Sebastian; Oliver Tüscher
Journal:  Curr Psychiatry Rep       Date:  2017-03       Impact factor: 5.285

7.  Neuroticism is a fundamental domain of personality with enormous public health implications.

Authors:  Thomas A Widiger; Joshua R Oltmanns
Journal:  World Psychiatry       Date:  2017-06       Impact factor: 49.548

8.  The True North Strong and Free? Opportunities for Improving Canadian Mental Health Care and Education by Adopting the WHO's ICD-11 Classification.

Authors:  Cary S Kogan; Sabrina Paterniti
Journal:  Can J Psychiatry       Date:  2017-06-30       Impact factor: 4.356

Review 9.  Suicide and suicidal behaviour.

Authors:  Gustavo Turecki; David A Brent
Journal:  Lancet       Date:  2015-09-15       Impact factor: 79.321

10.  Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders.

Authors:  Geoffrey M Reed; Michael B First; Cary S Kogan; Steven E Hyman; Oye Gureje; Wolfgang Gaebel; Mario Maj; Dan J Stein; Andreas Maercker; Peter Tyrer; Angelica Claudino; Elena Garralda; Luis Salvador-Carulla; Rajat Ray; John B Saunders; Tarun Dua; Vladimir Poznyak; María Elena Medina-Mora; Kathleen M Pike; José L Ayuso-Mateos; Shigenobu Kanba; Jared W Keeley; Brigitte Khoury; Valery N Krasnov; Maya Kulygina; Anne M Lovell; Jair de Jesus Mari; Toshimasa Maruta; Chihiro Matsumoto; Tahilia J Rebello; Michael C Roberts; Rebeca Robles; Pratap Sharan; Min Zhao; Assen Jablensky; Pichet Udomratn; Afarin Rahimi-Movaghar; Per-Anders Rydelius; Sabine Bährer-Kohler; Ann D Watts; Shekhar Saxena
Journal:  World Psychiatry       Date:  2019-02       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.